Laboratory checks for anti-AQP4 antibody are thus needed in diagnosis and treatment to determine whether interferon should be applied as a therapy, since the administration of interferon is considered effective for HAM but not for NMO (Araujo and Silva, 2006; Koga et al., 2009). The gene discussed is AQP4; the disease is tropical spastic paraparesis.